Results 71 to 80 of about 11,213 (177)

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer. [PDF]

open access: yesFuture Oncol
Westin SN   +29 more
europepmc   +1 more source

EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma. [PDF]

open access: yesESMO Open
Rosenberg JE   +19 more
europepmc   +1 more source

Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses. [PDF]

open access: yesJ Gynecol Oncol
Lee JY   +16 more
europepmc   +1 more source

Prof. Clovis Vincent

open access: yesArquivos de Neuro-Psiquiatria
Carlos Gama
doaj   +1 more source

IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer. [PDF]

open access: yesEur Urol
Cavka L   +25 more
europepmc   +1 more source

Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG Survey. [PDF]

open access: yesCancers (Basel)
Dimitrova D   +19 more
europepmc   +1 more source

Methodological Quality of Umbrella Reviews in Paediatric Dentistry: A Cross-Sectional Study. [PDF]

open access: yesInt Dent J
Gopinath VK   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy